Cargando…

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles

Detalles Bibliográficos
Autores principales:	Tagliamonte, M, Visciano, M, Tornesello, M, Buonaguro, FM, Buonaguro, L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767658/ http://dx.doi.org/10.1186/1742-4690-6-S3-P169

Ejemplares similares

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
por: Visciano, M, et al.
Publicado: (2009)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Structured particles for antigen presentation
por: Buonaguro, L, et al.
Publicado: (2006)

HPV monitoring in kidney transplanted patients
por: Buonaguro, Franco M, et al.
Publicado: (2012)

A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women
por: Tornesello, ML, et al.
Publicado: (2009)

Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
por: Naderi, HR, et al.
Publicado: (2006)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
por: Aricò, Eleonora, et al.
Publicado: (2005)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope
por: Hioe, CE, et al.
Publicado: (2009)

HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
por: Tagliamonte, Maria, et al.
Publicado: (2012)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

150 Carcinogenesis of HPV
por: Buonaguro, FM, et al.
Publicado: (2014)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
por: Visciano, Maria Luisa, et al.
Publicado: (2013)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
por: Manolio, Carmen, et al.
Publicado: (2022)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
por: Starita, Noemy, et al.
Publicado: (2018)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

HIV/HPV coinfection: state-of-the-art
por: Buonaguro, Franco M
Publicado: (2010)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
por: Buonaguro, Franco Maria, et al.
Publicado: (2015)

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
por: Tornesello, Maria Lina, et al.
Publicado: (2016)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
por: Cerasuolo, Andrea, et al.
Publicado: (2020)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022)

Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Corrigendum: Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Functional characterization of biodegradable nanoparticles as antigen delivery system
por: Petrizzo, A., et al.
Publicado: (2015)

P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens
por: Reddy, S Mohana Rama, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4ktbk2stmg2schkto2u52tofkf